ARCHIVES

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed

December 7, 1979

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

Annual Report Finds Cancer Incidence And Death Rates Fell For First Time.

December 5, 2008

Protein May Link Obesity To Cancer Aggressiveness

February 22, 2013

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992